Russell Investments Group’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.6M | Buy |
247,733
+18,284
| +8% | +$930K | 0.02% | 754 |
|
|
2025
Q1 | $10.3M | Buy |
229,449
+203,489
| +784% | +$9.17M | 0.01% | 809 |
|
|
2024
Q4 | $1.07M | Buy |
25,960
+1,945
| +8% | +$80.4K | ﹤0.01% | 1983 |
|
|
2024
Q3 | $937K | Buy |
24,015
+6,518
| +37% | +$254K | ﹤0.01% | 2047 |
|
|
2024
Q2 | $598K | Buy |
17,497
+16
| +0.1% | +$547 | ﹤0.01% | 2139 |
|
|
2024
Q1 | $439K | Buy |
17,481
+1,825
| +12% | +$45.8K | ﹤0.01% | 2243 |
|
|
2023
Q4 | $462K | Sell |
15,656
-765
| -5% | -$22.6K | ﹤0.01% | 2238 |
|
|
2023
Q3 | $519K | Sell |
16,421
-1,131
| -6% | -$35.7K | ﹤0.01% | 2218 |
|
|
2023
Q2 | $454K | Buy |
17,552
+3,271
| +23% | +$84.6K | ﹤0.01% | 2253 |
|
|
2023
Q1 | $343K | Sell |
14,281
-15,560
| -52% | -$374K | ﹤0.01% | 2368 |
|
|
2022
Q4 | $582K | Sell |
29,841
-172,394
| -85% | -$3.36M | ﹤0.01% | 2218 |
|
|
2022
Q3 | $4.25M | Buy |
202,235
+121,861
| +152% | +$2.56M | 0.01% | 1137 |
|
|
2022
Q2 | $1.56M | Buy |
80,374
+68,441
| +574% | +$1.33M | ﹤0.01% | 1720 |
|
|
2022
Q1 | $262K | Sell |
11,933
-26,159
| -69% | -$574K | ﹤0.01% | 2406 |
|
|
2021
Q4 | $606K | Buy |
+38,092
| New | +$606K | ﹤0.01% | 2371 |
|
|
2021
Q3 | – | Sell |
-2,600
| Closed | -$44K | – | 3149 |
|
|
2021
Q2 | $44K | Buy |
+2,600
| New | +$44K | ﹤0.01% | 3139 |
|